overall-survival

Documents about overall-survival

• Evidence thresholds for novel therapeutic strategies in prostate cancer: A consensus statement from the Prostate Cancer Committee of the French Urological Association#983969HAL (France)
• Deep Learning Can Predict the Overall Survival of Cervical Cancer Based on Histopathological Image, Gene Mutation and Clinical Information.#156940NCBI PubMed Central
• Preoperative Quality of Life as Predictor of Postoperative Early Recurrence and Overall Survival in Patients with Pancreatic and Periampullary Adenocarcinoma.#220832NCBI PubMed Central
• Machine Learning Models for Predicting Liver Metastasis at Diagnosis and Overall Survival in Ovarian Cancer: A SEER-Based Study.#244278NCBI PubMed Central
• Higher Blood-to-Tissue Tumor Mutational Burden Ratio Is Associated With Poorer Overall Survival in Advanced Non-Small Cell Lung Cancer#651104bioRxiv / medRxiv
• Urinary metabolomics may improve prediction of overall survival beyond tumor stage in colorectal cancer: results from the ColoCare study.#785587NCBI PubMed Central
• An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer#839758ClinicalTrials.gov
• Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients#980227ClinicalTrials.gov
• Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients#178233HAL (France)
• Postoperative radiotherapy in patients with R0 resection of soft tissue sarcoma: results from the European sarcoma CONTICABASE analysis#274142HAL (France)
• Safety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid Tumors#905941ClinicalTrials.gov
• Development and internal validation of a six-gene prognostic model based on galactose metabolism for overall survival in lung adenocarcinoma.#685610NCBI PubMed Central
• Correlation between resumption of employment and overall survival following awake mapping–based surgery for IDH-mutant grade 2 glioma: a consecutive series with 515 patients#388251HAL (France)
• Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer#308337HAL (France)
• A Machine Learning-Based Nomogram for Predicting Overall Survival in BCLC Stage 0-B Hepatocellular Carcinoma Patients with Low HALP Score.#406418NCBI PubMed Central
• A comparison of overall survival from early-onset and late-onset colorectal cancer stratified by TNM stage: a systematic review#642372Europe PMC
• A SEER based SHAP interpretable prognostic nomogram for overall survival in surgically treated patients with colorectal cancer and synchronous liver metastasis.#685555NCBI PubMed Central
• PSA Response as a Prognostic Factor of Overall Survival in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Apalutamide: Real-world Evidence#333014Dipòsit Digital de la Universitat de Barcelona
• Identification and Validation of Prognostic Biomarker Signatures Associated with Overall Survival in Colorectal Cancer: Evidence from Bioinformatics Analysis and an in vivo Study.#385213NCBI PubMed Central
• Development and external validation of a nomogram for overall survival in oral tongue squamous cell carcinoma using machine learning-assisted feature selection.#479284NCBI PubMed Central
• TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma#909189ClinicalTrials.gov
• The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study#1031355ClinicalTrials.gov
• Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations#898118ClinicalTrials.gov
• Prediction Model for Overall Survival in Patients with Epithelial Ovarian Cancer Undergoing Surgery and Systemic Therapy Based on the 2010–2021 SEER Database.#151447NCBI PubMed Central
• Artificial Intelligence Remote Patient Monitoring for Predicting Overall Survival for Patients Undergoing Radical Cystectomy for Bladder Cancer: Exploratory Analysis of the Prospective Trial.#213949NCBI PubMed Central
• Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial#326315HAL (France)
• Interpretable Machine Learning Models for Overall Survival Prediction in Stage I-II Endometrial Cancer Patients Receiving Postoperative Adjuvant Chemotherapy: A SEER-Based Study.#465099NCBI PubMed Central
• Non-interventional Study With Ra-223 Dichloride Assessing Overall Survival and Effectiveness Predictors for mCRPC Patients in a Real Life Setting in Germany#994683ClinicalTrials.gov
• Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing Perfusion#1031306ClinicalTrials.gov
• Role of Total Neoadjuvant Therapy in Non-Metastatic Mid and Low Rectal Cancer. Experience of the Medical Oncology Department at the Pierre and Marie Curie Center, Algiers#427369HAL (France)
• Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).#847200ClinicalTrials.gov
• Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients#1007345ClinicalTrials.gov
• Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint#801596ClinicalTrials.gov
• Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC#868884ClinicalTrials.gov
• Treatment and monitoring of men with metastatic castration-resistant prostate cancer#185247GUPEA
• Overall survival of patients with localized soft tissue sarcoma treated with or without adjuvant chemotherapy (DEEPSARC): a real world nationwide retrospective cohort study in France.#281194NCBI PubMed Central
• Prognostic associations between patient-reported outcomes and overall survival among patients with advanced squamous non-small cell lung cancer: results from the RATIONALE-307 trial.#298919NCBI PubMed Central
• Development and internal validation of an XGBoost-based prognostic prediction model and risk stratification system for overall survival in pediatric neuroblastoma: a SEER-based study.#452868NCBI PubMed Central
• Clinical, Radiologic, and Surgical Features of Brain Metastases in Colorectal Cancer. A Strong Correlation Between Surgical Patterns and Outcome#468476IRIS
• Frailty and Overall Survival of Older Patients Undergoing Radiotherapy for Head and Neck Cancer: A Prospective Analysis#644178IRIS
• Prognostic significance of NLRP-3 expression in solid cancers: a systematic review and meta-analysis#676295Europe PMC
• The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer#874329ClinicalTrials.gov
• A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617#994643ClinicalTrials.gov
• Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial#1005369The University of Melbourne Library Digital Repository
• The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)#902826ClinicalTrials.gov
• A Comparison of Factors Associated with Breast Cancer Stage at Diagnosis and 2-year Overall Survival Pre and During Covid-19 Periods in Johannesburg, South Africa#5043Europe PMC
• Development and validation of machine learning prognostic models for overall survival in non-surgical prostate cancer patients with bone metastases.#9669PubMed
• Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab#274199HAL (France)
• Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial#296807Gestión del Repositorio Documental de la Universidad de Salamanca
• Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study#326100HAL (France)